Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention R

第十一届 AACR 癌症预防前沿国际会议

• 批准号: 8461731
• 负责人: Margaret Foti
• 金额: $ 2.5万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-11 至 2013-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8461731
• 关键词: Advocate; American Association of Cancer Research; Attention; Awareness; Basic Science; Behavioral; Behavioral Sciences; California; Carcinogens; Clinical; Collaborations; Colonoscopy; Colorectal Cancer; Data; Discipline; Disease; Early Diagnosis; Early treatment; Education; Effectiveness; Epidemiology; Event; Evolution; Exercise; Exposure to; Fertilization; Fostering; General Population; Government; Head; Health Professional; Hepatitis B Virus; Human; Human Papillomavirus; Imaging Techniques; Incidence; Individual; Industry; Information Technology; International; Intervention; Learning; Lesion; Life Style; Mainstreaming; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Malignant neoplasm of lung; Mammography; Molecular; Pap smear; Patients; Physicians; Population; Premalignant; Prevention; Prevention Research; Prevention approach; Prevention strategy; Primary Prevention; Process; Public Health; Recurrence; Research; Research Personnel; Research Technics; Risk; Scientific Advances and Accomplishments; Scientist; Screening procedure; Second Primary Cancers; Secondary Prevention; Series; Shapes; Specific qualifier value; Survivors; Tobacco; Translating; cancer prevention; carcinogenesis; career; clinical application; frontier; interdisciplinary collaboration; interest; lectures; malignant breast neoplasm; mortality; posters; prevent; programs; skills; symposium; tertiary prevention; vaccine development

DESCRIPTION (provided by applicant): The Eleventh Annual International Conference on Frontiers in Cancer Prevention Research will take place October 16-19, 2012, at the Hilton Anaheim Hotel in Anaheim, California. The AACR has long been a supporter of cancer prevention research aimed at preventing cancer through lifestyle changes and early detection and treatment. This annual AACR conference debuted in 2002 and remains the pre-eminent cancer prevention research conference in the world. Physicians, scientists, patients, and survivor advocates learn about the latest translational discoveries from the leading basic, clinical, epidemiologic, and behavioral scientists in the field. The conference fosters interdisciplinary collaborations, accelerates progression in the field of prevention research, and promotes awareness of the vital importance of cancer prevention in reducing cancer incidence and mortality. The theme for this year's conference is "Integrative Cancer Prevention". The program will focus on identifying the factors that contribute to the initiation and evolution of cancer and how our understanding of these factors can be used to identify those at risk, identify approaches for prevention, and assess such approaches in the general population. The conference will not only focus on where the field of cancer prevention research is headed and how it is evolving, but will also help to shape and define the evolution of cancer prevention research. Bringing together basic, clinical, and population approaches in a unified way to study cancer prevention research in the broadest terms will help to promote cross-fertilization of scientists from diverse disciplines. Scientific advances are transforming the field of cancer prevention by providing us with the information and technology needed to understand the molecular underpinnings of carcinogenesis in humans and to identify and intervene in disease processes with unprecedented accuracy and effectiveness. By translating our understanding of the basic science into clinical application, benefits are being seen at the public health level. Several steps within carcinogenic initiation and progression are targets for cancer prevention. Primary prevention is the avoidance of exposure to carcinogens or the carcinogenic process and may be directed at the broad population of individuals who show no sign of pre-malignancy. Exercise and avoidance of tobacco are examples of this type of intervention. And one of the most successful primary prevention strategies is the development of vaccines such as those for HBV and HPV. Secondary prevention efforts are receiving a lot of attention and include screening and early detection, which are generally directed toward a more specified risk population. Examples of this type of prevention include pap test (for cervical cancer), mammography (for breast cancer), colonoscopy (for colorectal cancer) and emerging new imaging techniques to detect breast and lung cancer. Studies have found that premalignant lesions may be more common than previously realized and it will be crucial to understand who some premalignant lesions progress to cancer and others do not. Finally, tertiary prevention is aimed at preventing recurrence or second cancers. PUBLIC HEALTH RELEVANCE: This conference promotes public, academic, government, and industry awareness of the vital importance of cancer prevention research in reducing cancer incidence and mortality. It also catalyzes coordinated, focused research in basic, clinical, epidemiologic and behavioral science that promises to accelerate cancer prevention. Recent scientific advances are providing us with the information and technology needed to elucidate the molecular underpinnings of carcinogenesis in humans; understanding why some premalignant lesions progress to cancer while others do not will be crucial to personalizing therapy and avoiding overtreatment of patients. Through a combination of didactic lectures, poster presentations, educational sessions, and informal networking events, this conference provides a venue for scientists, physicians, and other health professionals to learn about and discuss the most cutting-edge research in the field and form interdisciplinary collaborations that will accelerate progression in cancer prevention research.

描述（由申请人提供）：2012年10月16日至19日在加利福尼亚州阿纳海姆市的希尔顿阿纳海姆酒店举行的第十十届预防癌症预防研究国际会议。长期以来，AACR一直是癌症预防研究的支持者，旨在通过改变生活方式的改变以及早期检测和治疗来预防癌症。该年度AACR会议于2002年首次亮相，仍然是世界上杰出的癌症预防研究会议。医师，科学家，患者和幸存者拥护者从该领域的主要基础，临床，流行病学和行为科学家那里了解了最新的翻译发现。会议促进了跨学科的合作，加快了预防研究领域的发展，并提高了人们对癌症预防在降低癌症发病率和死亡率中至关重要的认识。今年会议的主题是“预防综合癌症”。该计划将着重于确定有助于癌症开始和演变的因素，以及我们如何使用这些因素来识别有风险的因素，确定预防方法并评估普通人群中的这种方法。该会议不仅将着重于预防癌症预防研究的领域以及它的发展方式，而且还将有助于塑造和定义预防癌症预防研究的演变。以统一的方式将基本，临床和人口的方法汇总在一起，以最广泛的方式研究癌症预防研究，将有助于促进来自不同学科的科学家的交叉施肥。科学进步正在通过为我们提供了解人类癌变分子基础所需的信息和技术来改变癌症的领域，并以前所未有的准确性和有效性来识别和识别和干预疾病过程。通过将我们对基础科学的理解转化为临床应用，在公共卫生水平上正在看到益处。致癌开始和进展中的几个步骤是预防癌症的目标。一级预防是避免暴露于致癌物或致癌过程，并且可能针对不显示出恶性迹象的广泛人群。运动和避免烟草是这种干预措施的例子。最成功的主要预防策略之一是开发诸如HBV和HPV的疫苗。二级预防工作正在引起广泛关注，包括筛查和早期检测，通常针对更指定的风险人群。此类预防的例子包括PAP测试（用于宫颈癌），乳腺癌（用于乳腺癌），结肠镜检查（用于结肠直肠癌）和新兴的新成像技术，以检测乳腺癌和肺癌。研究发现，前病变可能比以前意识到的更为普遍，并且了解谁在癌症中进行的某些前病变发展至关重要。最后，第三级预防旨在防止复发或第二次癌症。 公共卫生相关性：这次会议促进了公众，学术，政府和行业对预防癌症预防研究至关重要的意识，以降低癌症的发病率和死亡率。它还在基本，临床，流行病学和行为科学方面催化了协调，集中研究，有望加速癌症的预防。最近的科学进步为我们提供了阐明人类癌变分子基础所需的信息和技术。理解为什么某些预调子病变会发展为癌症，而另一些人则对个性化治疗和避免患者过度治疗至关重要。通过教学演讲，海报演示，教育会议和非正式网络活动的结合，该会议为科学家，医师和其他卫生专业人员提供了一个场地，以了解和讨论该领域最尖端的研究并进行跨学科合作这将加速癌症预防研究的进展。